 Tabula Rasa HealthCare Inc NASDAQ: TRHC expects Q2 sales of 72 73 million, exceeding the prior guidance range of 66 69 million and the consensus of 67.61 million. Gordon Tunstall, TRHCs Lead Independent Director, said that the Board and management team have. 